Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1)

Abstract

Our results suggested that the increase in the atrial NO bioavailability could partially restore the duration of the plateau phase of CAF-remodelled AP by inhibiting the I(to1) as a result of the activation of non-canonical enzymatic pathways.